Hiroshima, Japan

Ryo Oda

This inventor holds 1 USPTO granted patent. Top assignees: Two Cells Co., Ltd., Other. Active years: 2006.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 18 
 
Two Cells Co., Ltd.
 patents
silverMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryo Oda - Innovator in Resistance Agents

Introduction

Ryo Oda is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of biotechnology, particularly in developing agents that confer resistance to external stimuli in animal cells.

Latest Patents

Ryo Oda holds a patent for an "Agent imparting resistance to external stimuli." This invention provides an agent for conferring resistance, comprising a lectin as an effective component. The agent is designed to enhance resistance against external stimuli to animal cells, particularly mammalian cells, and their cultured cells and various tissues in living bodies. The invention can confer resistance against mechanical stimuli and proteolytic reactions, thereby improving graft fixation of the cells and transplant tissues obtained through culturing.

Career Highlights

Throughout his career, Ryo Oda has worked with Two Cells Co., Ltd., where he has applied his innovative ideas to real-world applications. His work has been instrumental in advancing the understanding of cellular resistance mechanisms.

Collaborations

Ryo Oda has collaborated with notable individuals in his field, including Yukio Kato and Shinichi Tsutsumi. Their combined expertise has contributed to the success of various projects and innovations.

Conclusion

Ryo Oda's contributions to the field of biotechnology through his innovative patent demonstrate his commitment to enhancing cellular resistance mechanisms. His work continues to influence advancements in medical and scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…